NVE Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q2 2027 Earnings Release | 26 Oct 2026 |
Monitoring Framework
Key Performance Indicators
Product Sales Growth Annually240.0%
Gross Profit Margin Annually7,870.0%
Contract R&D Revenue Growth Annually-1,100.0%
Watch Items
- Customer Concentration RiskTrigger: Loss of or significant order reduction from key customers like Abbott LaboratoriesAction: Monitor quarterly product sales and supplier partnering agreement updates
- Gross Margin CompressionTrigger: Gross margin falling below 75% due to unfavorable product mix or increased distributor salesAction: Evaluate pricing strategies and direct-to-distributor sales ratios
Research as of 20 Jun 2026